F/M Emr Life Sciences in ETFLFSCETF

13F holders, Q2 2026 (June 30)
8holders +1
3new positions
2sold out
$45.20avg. 13F price*

At the end of Q2 2026, 8 institutions reported holding F/M Emr Life Sciences in ETF (LFSC) in their 13F filings, up 1 from Q1 2026. 3 opened new positions and 2 sold out. The largest holders were Emerald Mutual Fund Advisers Trust ($90.3M), Sbe LLC Dba Cedar Cove Wealth Partners ($3.2M) and Hunter Associates Investment Management LLC ($2.6M).

Company
F/M Emr Life Sciences in ETF
Filed as
RBB FD INC (Q2 2026)
CUSIP
74933W221
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q4 2024: 2Q4 2024Q1 2025: 4Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 7Q4 2025Q1 2026: 7Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions3$2.1M
Exits2$4K

All 13F filers, Q1 2026 → Q2 2026: 57,445 shares bought and 2,605 shares sold, net +54,840 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

Emerald Mutual Fund Advisers Trust 3.17% No change 1,997,035 $90.3M
Sbe LLC Dba Cedar Cove Wealth Partners 1.49% Add +0.2% 70,126 $3.2M
Hunter Associates Investment Management LLC 0.30% Add +16.1% 57,742 $2.6M
IHT Wealth Management, LLC 0.02% New 24,506 $1.1M
Atria Investments, Inc 0.01% Add +9.7% 24,506 $1.1M
Old Port Advisors 0.20% New 22,613 $1.0M
Tidal Investments LLC 0.00% Reduce -12.4% 17,474 $790K
FMR LLC 0.00% New 30 $1K

"% of holder's portfolio" is LFSC's weight in each manager's 13F, not the share of F/M Emr Life Sciences in ETF the manager owns.